- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth and its peers as on 30 April, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth | 3.46% | 0% | 1.33% | 6.19% | 8.78% | 10.53% | - | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 4.34% | 0.23% | 1.46% | 5.71% | 8.21% | 4.56% | 24.91% | 15.57% | 20.11% | 12.33% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -6.52% | -0.85% | -1.82% | 9.73% | -3.47% | 0.77% | 12.26% | 11.31% | 11.77% | 12.07% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 2.05% | -0.72% | 0.54% | 16.66% | 6.07% | 6.18% | 21.02% | 21.19% | 18.87% | 16.1% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.55% | -1.29% | -1.52% | 9.81% | 2.78% | 16.42% | 30.87% | 26.93% | 19.71% | 15.56% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -5.46% | -0.83% | -1.06% | 10.77% | 1.03% | -4.44% | 11.24% | 15.49% | 13.84% | 14.51% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | - | -0.3% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 4.52% | -0.48% | -1.98% | 2.91% | 0.11% | -2.66% | -5.52% | 6.11% | -3.89% | 6.51% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 5.88% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 93.48% | 2.86% (Arbitrage: 0.00%) | 0.00% | 0.00% | 3.66% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.35% |
| JB Chemicals & Pharmaceuticals Limited | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 8.90% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 5.77% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.31% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.24% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.93% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 3.85% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 3.79% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 3.17% |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 3.16% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.02% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.77% |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 2.61% |
| Corona Remedies Limited | INE02ZQ01018 | Pharmaceuticals & Biotechnology | 2.27% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.17% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.11% |
| Emcure Pharmaceuticals Limited | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 1.89% |
| Narayana Hrudayalaya Limited | NH (INE410P01011) | Healthcare Services | 1.72% |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.58% |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 1.56% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 1.42% |
| Navin Fluorine International Limited | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 1.41% |
| Aether Industries Limited | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 1.38% |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.35% |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 1.34% |
| Strides Pharma Science Limited | STAR (INE939A01011) | Pharmaceuticals & Biotechnology | 1.24% |
| Kovai Medical Center and Hospital Limited | INE177F01017 | Healthcare Services | 1.20% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 1.07% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 0.94% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.83% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 0.80% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 0.74% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.70% |
| Sudeep Pharma Limited | INE0QPI01025 | Pharmaceuticals & Biotechnology | 0.67% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.64% |
| Zota Health Care Limited | ZOTA (INE358U01012) | Pharmaceuticals & Biotechnology | 0.55% |
| Aarti Pharmalabs Limited | AARTIPHARM (INE0LRU01027) | Pharmaceuticals & Biotechnology | 0.48% |
| Tatva Chintan Pharma Chem Limited | TATVA (INE0GK401011) | Chemicals & Petrochemicals | 0.21% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.19% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 0.15% |
Debt
| Name | Rating | Weight % |
|---|---|---|
| 91 Days Tbill (MD 22/05/2026) | Sovereign | 0.89% |
| 182 Days Tbill (MD 28/05/2026) | Sovereign | 0.89% |
| 182 Days Tbill (MD 11/06/2026) | Sovereign | 0.36% |
| 364 Days Tbill (MD 07/05/2026) | Sovereign | 0.18% |
| 91 Days Tbill (MD 14/05/2026) | Sovereign | 0.18% |
| 91 Days Tbill (MD 04/06/2026) | Sovereign | 0.18% |
| 182 Days Tbill (MD 04/06/2026) | Sovereign | 0.14% |
| 182 Days Tbill (MD 09/04/2026) | Sovereign | 0.04% |
Portfolio data is as on date 31 March, 2026
NAV history
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 30 April, 2026 | 14.219 | 0% |
| 29 April, 2026 | 14.219 | 0.46% |
| 28 April, 2026 | 14.154 | -0.54% |
| 27 April, 2026 | 14.231 | 2.37% |
| 24 April, 2026 | 13.901 | -0.93% |
| 23 April, 2026 | 14.032 | 1% |
| 22 April, 2026 | 13.893 | 0.35% |
| 21 April, 2026 | 13.845 | -0.03% |
| 20 April, 2026 | 13.849 | -0.15% |
| 17 April, 2026 | 13.870 | 0.47% |
| 16 April, 2026 | 13.805 | -0.03% |
| 15 April, 2026 | 13.809 | 1.29% |
| 13 April, 2026 | 13.633 | -0.09% |
| 10 April, 2026 | 13.645 | 0.57% |
| 9 April, 2026 | 13.567 | 0.62% |
| 8 April, 2026 | 13.483 | 1.17% |
| 7 April, 2026 | 13.327 | 0.46% |
| 6 April, 2026 | 13.266 | 0.41% |
| 2 April, 2026 | 13.212 | -1.03% |
| 1 April, 2026 | 13.350 | -0.29% |
| 31 March, 2026 | 13.389 | -0.01% |
| 30 March, 2026 | 13.390 | -1.35% |
| 27 March, 2026 | 13.573 | -0.98% |
| 25 March, 2026 | 13.708 | 1.58% |
| 24 March, 2026 | 13.495 | 1.41% |
| 23 March, 2026 | 13.307 | -2.24% |
| 20 March, 2026 | 13.612 | 1.68% |
| 19 March, 2026 | 13.387 | -2.18% |
| 18 March, 2026 | 13.685 | 0.87% |
| 17 March, 2026 | 13.567 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth?
The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is 14.219 as on 30 April, 2026.What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth?
The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth are 3.46% as on 30 April, 2026.What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth?
The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth are 10.53% as on 30 April, 2026.